• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于参数和半参数混合治愈模型的SAS宏。

A SAS macro for parametric and semiparametric mixture cure models.

作者信息

Corbière Fabien, Joly Pierre

机构信息

EMI E0338 Biostatistique, Institut de Santé Publique et Développement, Université Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France.

出版信息

Comput Methods Programs Biomed. 2007 Feb;85(2):173-80. doi: 10.1016/j.cmpb.2006.10.008. Epub 2006 Dec 8.

DOI:10.1016/j.cmpb.2006.10.008
PMID:17157948
Abstract

Cure models have been developed to analyze failure time data with a cured fraction. For such data, standard survival models are usually not appropriate because they do not account for the possibility of cure. Mixture cure models assume that the studied population is a mixture of susceptible individuals, who may experience the event of interest, and non-susceptible individuals that will never experience it. The aim of this paper is to propose a SAS macro to estimate parametric and semiparametric mixture cure models with covariates. The cure fraction can be modelled by various binary regression models. Parametric and semiparametric models can be used to model the survival of uncured individuals. The maximization of the likelihood function is performed using SAS PROC NLMIXED for parametric models and through an EM algorithm for the Cox's proportional hazards mixture cure model. Indications and limitations of the proposed macro are discussed and an example in the field of cancer clinical trials is shown.

摘要

已开发出治愈模型来分析带有治愈比例的失效时间数据。对于此类数据,标准生存模型通常并不适用,因为它们没有考虑到治愈的可能性。混合治愈模型假定所研究的总体是由可能经历感兴趣事件的易感个体和永远不会经历该事件的非易感个体组成的混合体。本文的目的是提出一个SAS宏程序,用于估计带有协变量的参数化和半参数化混合治愈模型。治愈比例可以通过各种二元回归模型进行建模。参数化和半参数化模型可用于对未治愈个体的生存情况进行建模。对于参数化模型,使用SAS PROC NLMIXED执行似然函数最大化,对于Cox比例风险混合治愈模型,则通过期望最大化(EM)算法来执行。讨论了所提出宏程序的适用情况和局限性,并给出了癌症临床试验领域的一个示例。

相似文献

1
A SAS macro for parametric and semiparametric mixture cure models.用于参数和半参数混合治愈模型的SAS宏。
Comput Methods Programs Biomed. 2007 Feb;85(2):173-80. doi: 10.1016/j.cmpb.2006.10.008. Epub 2006 Dec 8.
2
Estimation method of the semiparametric mixture cure gamma frailty model.半参数混合治愈伽马脆弱模型的估计方法
Stat Med. 2008 Nov 10;27(25):5177-94. doi: 10.1002/sim.3358.
3
A new estimation method for the semiparametric accelerated failure time mixture cure model.半参数加速失效时间混合治愈模型的一种新估计方法。
Stat Med. 2007 Jul 20;26(16):3157-71. doi: 10.1002/sim.2748.
4
Estimating the proportion of cured patients in a censored sample.估计截尾样本中治愈患者的比例。
Stat Med. 2005 Jun 30;24(12):1865-79. doi: 10.1002/sim.2137.
5
Cure fraction estimation from the mixture cure models for grouped survival data.基于分组生存数据的混合治愈模型的治愈分数估计
Stat Med. 2004 Jun 15;23(11):1733-47. doi: 10.1002/sim.1774.
6
A semi-parametric accelerated failure time cure model.一种半参数加速失效时间治愈模型。
Stat Med. 2002 Nov 15;21(21):3235-47. doi: 10.1002/sim.1260.
7
Interval mapping of quantitative trait loci for time-to-event data with the proportional hazards mixture cure model.使用比例风险混合治愈模型对事件发生时间数据进行数量性状基因座的区间定位。
Biometrics. 2006 Dec;62(4):1053-61. doi: 10.1111/j.1541-0420.2006.00585.x.
8
Cure rate model with interval censored data.具有区间删失数据的治愈率模型。
Stat Med. 2008 Jan 15;27(1):3-14. doi: 10.1002/sim.2918.
9
Estimating and modeling the cure fraction in population-based cancer survival analysis.基于人群的癌症生存分析中治愈分数的估计与建模。
Biostatistics. 2007 Jul;8(3):576-94. doi: 10.1093/biostatistics/kxl030. Epub 2006 Oct 4.
10
An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks data.一种基于期望最大化(EM)的半参数混合模型方法用于竞争风险数据的回归分析。
Stat Med. 2003 Apr 15;22(7):1097-111. doi: 10.1002/sim.1371.

引用本文的文献

1
Application of Mixture and Non-mixture Cure Models in Survival Analysis of Patients With COVID-19.混合与非混合治愈模型在新冠肺炎患者生存分析中的应用
Cureus. 2024 Apr 18;16(4):e58550. doi: 10.7759/cureus.58550. eCollection 2024 Apr.
2
Laplacian-P-splines for Bayesian inference in the mixture cure model.拉普拉斯样条在混合治愈模型中贝叶斯推断的应用。
Stat Med. 2022 Jun 30;41(14):2602-2626. doi: 10.1002/sim.9373. Epub 2022 Mar 14.
3
Cancer immunotherapy trial design with random delayed treatment effect and cure rate.具有随机延迟治疗效果和治愈率的癌症免疫疗法试验设计。
Stat Med. 2022 Feb 20;41(4):786-797. doi: 10.1002/sim.9258. Epub 2021 Nov 15.
4
An improved method for the effect estimation of the intermediate event on the outcome based on the susceptible pre-identification.基于易感性预先识别的中间事件对结局影响的估计的改进方法。
BMC Med Res Methodol. 2021 Sep 21;21(1):192. doi: 10.1186/s12874-021-01378-8.
5
Model-based Recursive Partitioning for Survival of Iranian Female Breast Cancer Patients: Comparing with Parametric Survival Models.基于模型的伊朗女性乳腺癌患者生存递归划分:与参数生存模型的比较
Iran J Public Health. 2017 Jan;46(1):35-43.
6
A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.比例风险治愈模型下加权对数秩检验的一种新型样本量公式。
Pharm Stat. 2017 Jan;16(1):87-94. doi: 10.1002/pst.1790. Epub 2016 Nov 8.
7
A Comparison between Cure Model and Recursive Partitioning: A Retrospective Cohort Study of Iranian Female with Breast Cancer.治愈模型与递归划分的比较:伊朗乳腺癌女性的回顾性队列研究
Comput Math Methods Med. 2016;2016:9425629. doi: 10.1155/2016/9425629. Epub 2016 Aug 28.
8
Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection.参与血管形态发生和成熟的基因表达可预测接受肝切除患者基于贝伐单抗化疗的疗效。
Mol Cancer Ther. 2016 Nov;15(11):2814-2821. doi: 10.1158/1535-7163.MCT-16-0275. Epub 2016 Aug 17.
9
Sample size calculation for testing differences between cure rates with the optimal log-rank test.使用最优对数秩检验来检验治愈率差异时的样本量计算。
J Biopharm Stat. 2017;27(1):124-134. doi: 10.1080/10543406.2016.1148711. Epub 2016 Feb 16.
10
Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men.男男性行为者中丙型肝炎病毒的自发清除
Clin Infect Dis. 2015 Nov 1;61(9):1381-8. doi: 10.1093/cid/civ562. Epub 2015 Jul 14.